Rituximab Treatment in Myasthaenia Gravis: Report of two paediatric cases

Myasthaenia gravis (MG) is an auto-immune disease involving the postsynaptic receptors in the neuromuscular junction. The condition is characterised by fatigable weakness of the skeletal muscles and is uncommon in children. Acetylcholinesterase inhibitors and immune-modifying medications are usually...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sultan Qaboos Univ Med J
Autors principals: Koul, Roshan, Al-Futaisi, Amna, Abdelrahim, Rana, Mani, Renjith, Abdwani, Reem, Al-Asmi, Abdullah
Format: Artigo
Idioma:Inglês
Publicat: Sultan Qaboos University Medical Journal, College of Medicine & Health Sciences 2018
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6132519/
https://ncbi.nlm.nih.gov/pubmed/30210856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18295/squmj.2018.18.02.018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars